Maximizepuja15 Jul, 2024Business
The Clinical Oncology Next-Generation Sequencing Market size was valued at USD 9.49 Billion in 2023 and the total Clinical Oncology Next-Generation Sequencing revenue is expected to grow at a CAGR of 20.7 % from 2024 to 2030, reaching nearly USD 35.42 Billion by 2030. Clinical Oncology Next-Generation Sequencing is a high-throughput genomic analysis to identify tumor DNA mutations, guiding personalized cancer treatments through simultaneous examination of multiple genes. Advancements in technology, increasing prevalence of cancer worldwide, and growing demand for personalized medicine driving the growth of Clinical Oncology Next-Generation Sequencing Market.
Express Autocare
Steve Peckham
Bharat Floorings And Tiles
Lanka Taxis
Sarah Eberlin
Epoch Lasers
Steve Meyer
Hood Cleaning Solutions
Koitoto Bandar Togel
Lysandra Saphira